ATE264113T1 - Verwendung von protein c zur behandlung von thrombozytopenischer purpura und hämolytisches urämisches syndrom - Google Patents
Verwendung von protein c zur behandlung von thrombozytopenischer purpura und hämolytisches urämisches syndromInfo
- Publication number
- ATE264113T1 ATE264113T1 AT99961896T AT99961896T ATE264113T1 AT E264113 T1 ATE264113 T1 AT E264113T1 AT 99961896 T AT99961896 T AT 99961896T AT 99961896 T AT99961896 T AT 99961896T AT E264113 T1 ATE264113 T1 AT E264113T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- thrombocytopenic purpura
- uremic syndrome
- hemolytic uremic
- provides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4866—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11177098P | 1998-12-10 | 1998-12-10 | |
| PCT/US1999/028433 WO2000033867A1 (en) | 1998-12-10 | 1999-12-01 | Method of treating thrombocytopenic purpura and hemolytic uremic syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE264113T1 true ATE264113T1 (de) | 2004-04-15 |
Family
ID=22340356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99961896T ATE264113T1 (de) | 1998-12-10 | 1999-12-01 | Verwendung von protein c zur behandlung von thrombozytopenischer purpura und hämolytisches urämisches syndrom |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20010003740A1 (de) |
| EP (1) | EP1137432B1 (de) |
| JP (1) | JP2002531519A (de) |
| CN (1) | CN1329503A (de) |
| AT (1) | ATE264113T1 (de) |
| AU (1) | AU1838500A (de) |
| BR (1) | BR9915984A (de) |
| CA (1) | CA2351555A1 (de) |
| DE (1) | DE69916493T2 (de) |
| ES (1) | ES2219094T3 (de) |
| IL (1) | IL142249A0 (de) |
| WO (1) | WO2000033867A1 (de) |
| ZA (1) | ZA200102730B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2002028416A1 (ja) * | 2000-09-30 | 2004-02-12 | 持田製薬株式会社 | 溶血性貧血の予防・治療剤 |
| CA2668187A1 (en) * | 2006-10-31 | 2008-06-19 | The Scripps Research Institute | Dosing regimen of activated protein c and variants having reduced anticoagulant activity |
| CN105833255A (zh) * | 2016-03-23 | 2016-08-10 | 兆科药业（合肥）有限公司 | 抗血小板溶栓素在制备治疗血栓性血小板减少性紫癜的药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5516650A (en) * | 1985-06-27 | 1996-05-14 | Zymogenetics, Inc. | Production of activated protein C |
| ID22933A (id) * | 1997-04-28 | 1999-12-16 | Lilly Co Eli | Fomulasi protien c terakivasi |
-
1999
- 1999-12-01 EP EP99961896A patent/EP1137432B1/de not_active Expired - Lifetime
- 1999-12-01 IL IL14224999A patent/IL142249A0/xx unknown
- 1999-12-01 CN CN99814123A patent/CN1329503A/zh active Pending
- 1999-12-01 BR BR9915984-8A patent/BR9915984A/pt not_active Application Discontinuation
- 1999-12-01 ES ES99961896T patent/ES2219094T3/es not_active Expired - Lifetime
- 1999-12-01 JP JP2000586357A patent/JP2002531519A/ja not_active Withdrawn
- 1999-12-01 DE DE69916493T patent/DE69916493T2/de not_active Expired - Fee Related
- 1999-12-01 WO PCT/US1999/028433 patent/WO2000033867A1/en active IP Right Grant
- 1999-12-01 AU AU18385/00A patent/AU1838500A/en not_active Abandoned
- 1999-12-01 AT AT99961896T patent/ATE264113T1/de not_active IP Right Cessation
- 1999-12-01 CA CA002351555A patent/CA2351555A1/en not_active Abandoned
-
2000
- 2000-12-07 US US09/731,467 patent/US20010003740A1/en not_active Abandoned
-
2001
- 2001-04-03 ZA ZA200102730A patent/ZA200102730B/en unknown
-
2003
- 2003-06-24 US US10/602,936 patent/US20040087643A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20040087643A1 (en) | 2004-05-06 |
| BR9915984A (pt) | 2001-09-04 |
| US20010003740A1 (en) | 2001-06-14 |
| ZA200102730B (en) | 2002-07-03 |
| DE69916493T2 (de) | 2005-03-24 |
| EP1137432A1 (de) | 2001-10-04 |
| ES2219094T3 (es) | 2004-11-16 |
| AU1838500A (en) | 2000-06-26 |
| EP1137432B1 (de) | 2004-04-14 |
| IL142249A0 (en) | 2002-03-10 |
| WO2000033867A1 (en) | 2000-06-15 |
| CN1329503A (zh) | 2002-01-02 |
| JP2002531519A (ja) | 2002-09-24 |
| DE69916493D1 (de) | 2004-05-19 |
| CA2351555A1 (en) | 2000-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY180762A (en) | Combination therapy comprising glucose reabsorption inhibitors and ppar modulators. | |
| DE69815090D1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| ATE234092T1 (de) | 2-alkylpyrrolidine | |
| ATE302015T1 (de) | Zusammensetzung, welche apoptosis verhindert, methode zur reinigung dieser zusammensetzung und verwendungen davon | |
| DE69635671D1 (de) | Verwendung von roxithromycin zur herstellung eines medikaments zur verbesserung der biologischen und antiviralen aktivität von protease-inhibitoren | |
| DE69508192D1 (de) | Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen | |
| DE69830751D1 (de) | Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen | |
| DE69915033D1 (de) | Verfahren zur keimungshemmende behandlung von knollen und zwiebeln mit eugenol und/oder isoeugenol | |
| DE69831000D1 (de) | Verwendung von cytidin und cytosin-enthaltenden verbindungen zur behandlung von reizmittelgelgebrauch | |
| DE60229406D1 (de) | Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en) | |
| GB0216001D0 (en) | Process and composition | |
| WO2021195470A3 (en) | Identification and use of compounds in the treatment or prevention of severe acute respiratory syndrome coronavirus 2 | |
| DE69333711D1 (de) | Compactin zur behandlung von entzündungen | |
| IL142220A0 (en) | Method of treating viral hemorrhagic fever | |
| DE3686108D1 (de) | Verwendung von p-chlorophenoxyazetat von n,n-dimethylbiguanid zur behandlung von neuropathien und nervendegeneration. | |
| ATE264113T1 (de) | Verwendung von protein c zur behandlung von thrombozytopenischer purpura und hämolytisches urämisches syndrom | |
| PT855916E (pt) | Composicao farmaceutica contendo um estimulador de activina ou inibina | |
| MX9605072A (es) | Dispositivo dispensador para pretratamiento. | |
| ATE288498T1 (de) | Methoden zur inhibierung von helicobacter pylori | |
| ATE244008T1 (de) | Verwendung von makroliden zur behandlung von akuten lungenverletzungen | |
| DE69330465D1 (de) | Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4-aza-5 alpha-androst-1-en-3-one | |
| DE69905489T2 (de) | Protein c zur behandlung von sichelzellanämie und thalassämie | |
| DE60034110D1 (de) | Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien | |
| DE69930419D1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie | |
| NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |